These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6848233

  • 1. Effects of oral verapamil in patients with atrioventricular reentrant tachycardia incorporating an accessory pathway.
    Wu D, Kou HC, Yeh SJ, Lin FC, Hung JS.
    Circulation; 1983 Feb; 67(2):426-33. PubMed ID: 6848233
    [Abstract] [Full Text] [Related]

  • 2. Serial electrophysiologic studies of the effects of oral diltiazem on paroxysmal supraventricular tachycardia.
    Yeh SJ, Fu M, Lin FC, Lee YS, Hung JS, Wu D.
    Chest; 1985 May; 87(5):639-43. PubMed ID: 3987375
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
    Klein GJ, Gulamhusein S, Prystowsky EN, Carruthers SG, Donner AP, Ko PT.
    Am J Cardiol; 1982 Jan 15; 49(1):117-24. PubMed ID: 7053599
    [Abstract] [Full Text] [Related]

  • 5. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Wellens HJ, Tan SL, Bär FW, Düren DR, Lie KI, Dohmen HM.
    Br Heart J; 1977 Oct 15; 39(10):1058-66. PubMed ID: 911555
    [Abstract] [Full Text] [Related]

  • 6. Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia.
    Tonkin AM, Aylward PE, Joel SE, Heddle WF.
    J Cardiovasc Pharmacol; 1980 Oct 15; 2(5):473-86. PubMed ID: 6157944
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
    Belhassen B, Glick A, Laniado S.
    Circulation; 1988 Apr 15; 77(4):795-805. PubMed ID: 3349581
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
    Rowland E, McKenna WJ, Krikler DM.
    Am J Cardiol; 1985 Jun 01; 55(13 Pt 1):1513-9. PubMed ID: 3873867
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiologic study on atrioventricular nodal reetrant tachycardia with special reference to recent controversies.
    Suzuki F, Hiejima K, Momoi H.
    Jpn J Med; 1983 Aug 01; 22(3):206-18. PubMed ID: 6620709
    [Abstract] [Full Text] [Related]

  • 11. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 12. Effects of quinidine on atrioventricular nodal reentrant paroxysmal tachycardia.
    Wu D, Hung JS, Kuo CT, Hsu KS, Shieh WB.
    Circulation; 1981 Oct 01; 64(4):823-31. PubMed ID: 7273382
    [Abstract] [Full Text] [Related]

  • 13. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
    Gomes JA, Hariman RJ, Kang PS, Chowdry IH.
    J Am Coll Cardiol; 1985 Jan 01; 5(1):45-57. PubMed ID: 3964808
    [Abstract] [Full Text] [Related]

  • 14. The excitable gap in atrioventricular nodal reentrant tachycardia. Characterization with ventricular extrastimuli and pharmacologic intervention.
    Schuger CD, Steinman RT, Lehmann MH.
    Circulation; 1989 Aug 01; 80(2):324-34. PubMed ID: 2752559
    [Abstract] [Full Text] [Related]

  • 15. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
    Sakurai M, Yasuda H, Kato N, Nomura A, Fujita M, Nishino T, Fujita K, Koike Y, Saito H.
    Am Heart J; 1983 Apr 01; 105(4):619-28. PubMed ID: 6837416
    [Abstract] [Full Text] [Related]

  • 16. Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction.
    Kou HC, Hung JS, Lee YS, Wu D.
    Circulation; 1982 Aug 01; 66(2):454-62. PubMed ID: 6807567
    [Abstract] [Full Text] [Related]

  • 17. Effects of acebutolol on paroxysmal atrioventricular reentrant tachycardia in patients with manifest or concealed accessory pathways.
    Kou HC, Yeh SJ, Lin FC, Hung JS, Wu D.
    Chest; 1983 Jan 01; 83(1):92-7. PubMed ID: 6848337
    [Abstract] [Full Text] [Related]

  • 18. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia.
    Sethi KK, Singh B, Kalra GS, Arora R, Khalilullah M.
    Indian Heart J; 1994 Jan 01; 46(3):141-4. PubMed ID: 7821934
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.